Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0035 Transporter Info | ||||
Gene Name | SLC30A8 | ||||
Transporter Name | Zinc transporter 8 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Valproic Acid results in decreased methylation of SLC30A8 gene | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of SLC30A8 promoter | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Benzo(a)pyrene results in decreased methylation of SLC30A8 3' UTR | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
3-iodothyronamine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SLC30A8 mRNA affects the uptake of 3-iodothyronamine | [6] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A results in decreased expression of SLC30A8 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased abundance of Cadmium which results in increased expression of SLC30A8 mRNA | [10] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to SLC30A8 gene | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
entinostat |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
entinostat results in increased expression of SLC30A8 mRNA | [3] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Fulvestrant |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Fulvestrant results in increased methylation of SLC30A8 gene | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Glucose |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SLC30A8 protein promotes the reaction Glucose results in increased secretion of INS protein | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Zinc |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SLC30A8 protein affects the localization of Zinc | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
SLC30A8 protein results in increased abundance of Zinc | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
SLC30A8 protein results in increased transport of Zinc | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
SLC30A8 protein results in increased uptake of Zinc | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Mycotoxins |
|||||
Aflatoxin B1 |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 results in decreased methylation of SLC30A8 gene | [7] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Aflatoxin B1 results in increased methylation of SLC30A8 intron | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Valproic Acid |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid affects the expression of SLC30A8 | [1] | |||
Drug in Phase 3 Trial |
|||||
Triclosan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Triclosan inhibits the expression of SLC30A8 | [4] | |||
Drug in Phase 2 Trial |
|||||
MS-275 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
MS-275 increases the expression of SLC30A8 | [3] | |||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol A inhibits the expression of SLC30A8 | [5] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene inhibits the expression of SLC30A8 | [2] | |||
Cadmium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased abundance of Cadmium which results in increased expression of SLC30A8 mRNA | [10] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.